OrliLab welcomes corrections, source suggestions and feedback about its U.S.-focused educational content on orlistat, Alli, Xenical and other weight-management medications. Use the form for website-related questions or to flag a factual or regulatory issue. This channel is not a pharmacy, medical consultation service, emergency line or prescription request form.
Use the form below to identify the page or passage that needs attention. Include the URL and explain what appears inaccurate, outdated or unclear. For regulatory questions, a direct link to the relevant FDA or DailyMed record is especially useful.
Please limit the message to the content issue. Do not provide diagnoses, medical histories, prescription numbers or other sensitive information. The form requests an email address so the site operator can respond when appropriate.
We welcome corrections concerning ingredient identity, branded and generic products, strength, OTC-versus-prescription classification, approved indications, clinical trial interpretation and warnings. Identify the exact statement and explain which evidence supports a different reading.
For example, an article about Alli 60 mg should not automatically apply the prescription Xenical 120 mg label, and a semaglutide product should not inherit another brand’s FDA indication without verification. The relevant product label or approval record is more useful than a general sales listing.
U.S. medicine labeling and drug safety guidance can change. If a page does not reflect an updated contraindication, FDA safety communication, brand transition or approval status, please provide the publication date and a reliable supporting source.
The FDA’s June 2026 changes to Alli kidney warnings are an example of information that deserves product-specific attention. An FDA approval, an NDC listing and current retail inventory are different types of facts; a correction should identify which one is at issue.
Useful submissions may reference FDA-approved prescribing information, DailyMed, Drugs@FDA, the FDA Orange Book, FDA Drug Safety Communications, MedlinePlus, state pharmacy licensing authorities or peer-reviewed studies that directly support a claim.
We consider source quality, relevance to the exact product and strength, U.S. jurisdiction, study population and date. Submitting a reference does not guarantee publication or a particular editorial conclusion.
Our Editorial Policy describes sourcing, accuracy, commercial independence and corrections. The Medical Review Process and Medical Reviewer explain how clinically sensitive material may be evaluated and how actual professional review should be attributed.
A process description is not a claim that every article has been signed off by a physician. If you believe a review credit is inaccurate or unsupported, identify the page and your concern.
OrliLab cannot diagnose a condition, choose a weight-management treatment, prescribe or refill medicine, review medical records, provide individualized dosing instructions or decide whether a particular drug is safe for you. The site also cannot resolve pharmacy orders, refund purchases made with third parties or guarantee that a retailer has inventory.
For questions about your own treatment, consult your prescriber or pharmacist. For a medical emergency, seek appropriate emergency services immediately rather than submitting this form.
Do not submit government identification, full birth dates, insurance member numbers, payment-card details, prescription photographs, laboratory reports, detailed medical histories or information concerning another person’s health. A URL and a short description are normally enough to evaluate a content correction.
Information voluntarily entered in this form is subject to the Privacy Policy. If you have a privacy request, choose that topic in the form without including unrelated sensitive records.
OrliLab is an affiliate-supported educational publisher, not the dispensing pharmacy or an operator of third-party telehealth services linked from the website. We cannot confirm real-time stock, prices, prescription decisions, insurance approval, order tracking or merchant refunds.
If a linked merchant or service makes a concerning claim, send the exact public-facing URL and a description. For personal transactions, contact the actual service provider through its official support and privacy channels.
Website feedback may be evaluated against the relevant source and page context. We may clarify a statement, add a qualification, correct an error or decide that the available evidence does not support a change. Significant safety issues warrant particular care.
There is no guaranteed response or publication time. We may be unable to give individual replies, especially when a submission asks for medical care or contains information that should not have been sent.
Our About page explains the site’s purpose, scope and commercial disclosures. The Terms of Use covers limitations of website information and third-party services.
If your question is about an actual orlistat prescription, a particular OTC package or a new side effect, the appropriate professional or licensed pharmacy is a better point of contact than OrliLab.